From diastolic dysfunction to exercise intolerance: an in silico simulation study on the phenotypic markers of heart failure with preserved ejection fraction

29 August 2020 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mr Tim Van Loon

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

274 More presentations in this session

Presentation thumbnail

Increased myocardial fat supply improves cardiac energetics and function in heart failure

Doctor W. Watson (Cambridge, GB)

Abstract Slides

Presentation thumbnail

Cardiac aging is regulated by autophagic disorder mediated by chronic inflammation via the Rubicon/NOX4 pathway.

Doctor T. Kamihara (Obu, JP)

Abstract Slides

Presentation thumbnail

Participants with diabetes have less augmentation in cardiac function and energetics in response to increased supply of fatty acid

Doctor P. Green (Hobart, AU)

Abstract Slides

Presentation thumbnail

Impaired high-density lipoprotein function in patients with heart failure

Ms L. Emmens (Groningen, NL)

Abstract Slides

Presentation thumbnail

The comparison of clinical significance between atrial and ventricular structural remodeling in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry

Doctor M. Okada (Osaka, JP)

Abstract Slides

Access the full session

Session thumbnail

Chronic Heart Failure ePosters

The Event

ESC Congress 2020

29 August - 1 September 2020

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources